Table 1. Clinical data of patients in the study population with ovarian LMP tumours and adenocarcinomas.

Age (years)
Median (range)	51.6 (20–86)
Histological type
LMP tumours
Serous	29 (67.4%)
Mucinous	14 (32.6%)
Adenocarcinomas
Serous	34 (40%)
Mucinous	10 (11.76%)
Endometrioid	16 (18.82%)
Clear cell	18 (21.17%)
Poorly differentiated	3 (3.5%)
Not specified	4 (4.7%)
Histologic grade
1	13 (15.3%)
2	240 (47.1%)
3	32 (37.6%)
FIGO stage
I	25 (29.5%)
II	3 (3.5%)
III	42 (49.4%)
IV	11 (12.9%)
Not specified	4 (4.7%)
Primary residual tumour
No	39 (45.9%)
Yes	46 (54.1%)
Adjuvant chemotherapy
Platinum-containing	64 (75.3%)
Non platinum-containing	21 (24.7%)
Clinical outcome
Died of ovarian cancer	26 (30.6%)
Alive	53 (62.4%)
Not specified	6 (0.7%)